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ABSTRACT 
Fungi are microorganisms that cause primarily non-life threatening infections in 
immunocompetent hosts and invasive and fatal ones in immunocompromised subjects. Cancer 
patients, autoimmune diseases carriers, transplant recipients, HIV/AIDS patients or people under 
treatment with immunosuppressive agents are at higher risk of developing invasive mycoses. 
Although not common, immunocompetent people can develop fungal infections with fatal 
outcomes. The purpose of this review is to verify the occurrence of death by mycoses in 
immunocompetent humans in cases confirmed through autopsies published within the last ten 
years.  
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INTRODUCTION 
Fungi are eukaryotic organisms that can exist in the form of independent single cells, yeasts,and 
can be based on hyphal threads,molds[1]. They can infect humans and cause various diseases from 
superficial infections of the skin and mucosal surfaces to invasive infections of internal organs [2]. 
In immunocompetent subjects, these microorganisms cause primarily superficial or non-life 
threatening infections [3], since the immune response is activated in order to eliminate the 
pathogen [4], while more invasive and fatal in immunocompromised people [5]. Amongst this 
group, transplant recipients have a significant risk of invasive fungal diseases [5], since they are 
under treatment with immunosuppressive drugs [6]. Other groups at risk include people with HIV 
[7], haematological malignancies [8, 9], patients with autoimmune diseases [10] and any other 
under treatment with corticosteroid agents [11, 12]. Chronically ill patients, like those with liver 
diseases and diabetes are also at risk of developing mycoses [13]. 
Amongst the causes of mycoses in all populations, major fungal pathogens include Candida 
albicans, Cryptococcus neoformans, Aspergillus fumigatus and Histoplasma capsulatum[2], and 
a simple laboratory tool to detect these fungal infections is to test for  1-3 β D glucan[14], which 
is a major constituent of fungal cell walls[15], in patient’s samples. Many cases of fungal infections 
are mistaken with bacterial, so Gram Stain, although non-specific, is important to rule out any 
bacterial diagnosis before initiating antimicrobial treatment [16]. 
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When in life diagnosis is not possible, it is important to have autopsies performed to rate the 
incidence of these infections [1].These results are of fundamental importance to define healthcare 
policies [17] and also correlate them to the clinical signs and symptoms the patients present upon 
hospital admission so that clinicians can direct the course of treatment in a more successful manner 
to save the new patient’s lives. 
The purpose of this review is to verify the occurrence of death by mycoses in immunocompetent 
humans in cases confirmed through autopsies published within the last ten years.  
 
MATERIALS AND METHODS 
This is a narrative review of literature.  
 
Article search 
All articles used in this review were searched on Pubmed using the following keywords: mycoses 
AND autopsy. A 10 years filter was included.  
 
Inclusion criteria 
All articles included in this review were case reports of immunocompetent humans with death and 
autopsy findings of mycoses. 
 
Exclusion criteria 
Immunocompromised people, including diabetics, transplant recipients, solid cancer and blood 
malignancies patients, HIV/AIDS, autoimmune disease subjects, people under treatment with 
corticosteroids, people with cirrhosis or history of tobacco abuse, were excluded from this review. 
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RESULTS  
The research using the described terms generated 227 results of which only 10 were eligible for 
this review, comprising 10 cases reports of death by mycoses confirmed through autopsy. The 
summarized compilation of the cases that matched our inclusion criteria is presented in table 1.  
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Table 1.  Fatal cases of mycoses confirmed with autopsy 
Year Author Subject 
Age, Gender 
Symptoms/complaints upon hospital 
admissions 
Diagnosis Fungi species 
2010 Ortmann et al 53, F Hypothermia and asystolia C Pseudallescheria boydii 
2010 Terada 36, M Hemoptysis and mental sickness C Cryptococcus neoformans 
2012 Kawakami 68, F Gradual mental deterioration, dyspnea 
and cardiac arrest one day after 
admission 
L Aspergillus fumigatus 
2012 Ochiai et al 21, F Mild neck stiffness without 
neurological symptoms 
A Phaeohyphomycosis* 
2013 Ubesie et al 13, F Neck masses of 3 years, body swelling 
of 3 months and reduction in urinary 
output of 2 months 
A Histoplasma capsulatum 
2014 Chatterjee 29, M Low grade intermittent fever of 3 
months with occasional rigor 
A Aspergillus flavus 
2014 Ramsi et al 13, M Influenza-like symptoms, fever, 
abdominal and neck pain. 
Febrile, tachycardic, hypotensive and 
respiratory distress.  
A Coccidioides spp. 
2015 Parikh et al 70, M Abdominal pain and inability to pass 
stool for 8 days 
A Aspergillus spp. 
6 
 
2015 Yuan and 
Prayson 
55, F Headaches behind left eye, blurred 
vision and scotoma 
A Aspergillus spp. 
2017 Bonsignore et al 43, F Fever of unknown origin A Histoplasma capsulatum 
F= female; M= male; A= autopsy; C= culture; L=laboratory 
*type of fungal infection 
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In 2010, Ortmann and col reported the case of a 53-year-old woman that plunged into a canal in 
the Netherlands and was submerged for 20 minutes. At resuscitation, there occurred severe 
aspiration of mud and water, severe hypothermia and asystole until successful resuscitation. For 
the next 6 weeks, she was treated with respiratory therapy. Bronchopneumonia was successfully 
treated with antibiotics. Candida albicans, Burkholderia cepacian and Pseudallescheria boydii 
were cultured following bronchoalveolar lavage. Tomography showed interstitial affection of the 
lungs and nephrocalcinosis. With antimycotic therapy, she recovered well. Until she was 
discharged, she complained about neck pain and headaches. She continued the antifungal therapy 
at home. She started feeling nausea and gastric pain was readmitted in the hospital and presented 
hyponaltremia and hypocalcemia and therapy was discontinued. She was then discharged but soon 
later readmitted again with nausea, vomiting and vertigo, presenting hyper fibrinogemia. 
Abdominal sonography showed an aneurism of the abdominal aorta. Brain tomography showed 
enhancements surrounding the brain ventricles, a hydrocephalus and, and signs of local pressure 
and she started having double vision. A new tomography showed stenosis of the middle cerebral 
artery and accumulation of cerebral liquor, that showed increase of cells and proteins, indicating 
inflammation. She then suffered from a severe subarachnoid bleeding from an unknown aneurism 
of the posterior cerebral artery and died 25 days after the last hospitalization. Multiple fungal 
aneurisms were found affecting the posterior cerebral arteries, the posterior communicating 
arteries, and the bifurcations of the left internal carotid artery. After death, P. Boydii was cultured 
from heart blood and from aortic tissue [18]. 
Tadashi Terada, in 2010, described the case of a 36-year-old Japanese man that was a company 
office worker and lived in a city where Cryptococcus is not endemic. His past history included 
lumbar disk herniation, bullae of lung, and pneumothorax. His family showed no fungal or 
immunosuppressive diseases. He had no history of travelling to foreign countries or endemic areas. 
He wasn’t obese, diabetic, asthmatic nor user of steroids and other drugs. Chest X-ray revealed a 
small cavity in the left lower lobe. Brain computed tomography (CT) showed edema, but no mass 
lesions. He developed fever, somnolence, nuchal stiffness, positive abnormal neurological 
reactions, such as Babinski and Kernich reactions, and increased muscular tonus. He soon went 
into a coma and received a respirator. Cryptococcus neoformans was detected in liquor on day 11. 
Leukocytes count was low and serum total protein, albumin and globulin were almost normal. In 
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blood, he presented low total protein, low total cholesterol and high glucose. He was treated with 
intravenous amphotericin B, but died on day 18 after hospitalization [19].   
Kawakami and col  (2012) reported a case of disseminated aspergillosis associated with tsunami 
lung (a disorder contracted after near drowning) in a 68-year-old woman that almost drowned in 
Japan after the 2011 earthquake. She was previously healthy and had no medical history. She was 
admitted into a hospital 7 hours after the near drowning experience with clear consciousness and 
ability to walk by herself. She gradually developed dyspnea and mental deterioration that was 
followed by cardiac arrest with resuscitation on the next day after admission. She was then 
transferred into the authors’ hospital where she was intubated and sedated. Blood tests were altered 
and 1-3 β D glucan levels were not assessed since fungi infections weren’t suspected for she wasn’t 
immunocompromised. Imaging exams showed  diffuse bilateral infiltrates and posterior atelectasis 
in the chest. Head tomography showed no abnormalities and cardiovascular monitoring showed 
elevated levels of extravascular lung water and increased pulmonary vascular permeability index. 
Despite antibiotics treatment, her respiratory function did not improve, so the presence of 1-3 β D 
glucan was tested on day 10 and presented elevated. It was started antifungal treatment, but her 
conditions continued to worsen. She died on day 18 [20]. 
Ochiai and col reported, in 2012, a case of cerebral phaeohyphomycosis in a 21-year-old house 
wife with no contributory history that experienced an acute episode of pyrexia and headache. On 
admission, she was alter and had mild neck stiffness without neurological symptoms. Imaging 
exams showed no abnormalities and liquor presented altered levels of cell count, protein and 
glucose and high 1-3 β D glucan level, indicating fungal infection. She was diagnosed with fungal 
meningitis, administered voriconazole and her condition improved, having her discharged from 
the hospital. However, she returned two other times to the hospital with signs of meningitis, had 
antifungal systemically administered and was discharged. She was given a diagnosis of Aspergillus 
niger infection, even though no culture was made. After 43 months after onset of symptoms, she 
died. On autopsy, it was identified multiple sharply branched septate hyphae  with melanin 
pigments. From these findings, A. niger infection was ruled out and phaeohyphomycosis was 
diagnosed [21]. 
Ubesie and col reported a case in 2013 of a 13-year-old girl that was admitted for 16 days and 
presented neck masses of 3 years duration, generalized body swelling of 3 months and had a 
reduction in urinary output for 2 months. She took native medications for 1 year in the course of 
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illness and had 2 episodes of convulsion prior to hospitalization. There was no history of using 
antibiotic drugs, chemotherapy or steroids that may have caused immunosuppression. Tests for 
HIV and tuberculosis were negative. She had respiratory distress, looked pale and generalized 
body swelling and significant generalized lymphadenopathy. Blood pressure was high and oxygen 
saturation was under 88%. She was diagnosed with nephritic syndrome possibly secondary to a 
lymphoma. However, ascitic fluid cytology was negative for malignant cells. At day 16, she passed 
away. On autopsy it was revealed marked enlargement of  the axillary, cervical, hilar mediastinal, 
para-aortic and mesenteric lymph node groups. Microscopic examination of these lymph nodes 
showed intracellular and extracellular haematoxylinophilic bodies, each surrounded by a small 
halo, corresponding to Histoplasma characteristics that, based on their size, were classified as 
Histoplasma capsulatum [22]. 
In 2014, Chatterjee and col reported two autopsy cases of fibrosing mediastinitis with dominant 
cardiac involvement due to Aspergillus. A man of 29 years from North India presented intermittent 
and low grade fever for 3 months and occasional rigor. He developed shortness of breath on 
exertion associated with productive cough and occasional hemoptysis. A tomography of the chest 
showed a homogenous plaque-like soft tissue mass encasing the heart, inseparable from 
pericardium and walls of cardiac chambers. The mass was also encasing the tracheobronchial tree, 
pulmonary arteries and entire aorta. No necrosis and calcification was noted. The clinical diagnosis 
was rheumatic heart disease with a mediastinal tumor. The patient was administered antibiotics, 
but died before a biopsy was performed. In autopsy, it was identified a firm-to-hard infiltrative and 
fibrous lesion. Microscopy showed fungal profiles consistent with morphology of Aspergillus spp. 
DNA sequencing identified the species as Aspergillus flavus [23]. 
In a case of acquired haemophagocytic lymphohistiocytosis due to coccidioidomycosis, Ramsi and 
col described in 2014 a case of a 13-year-old healthy boy from Central California that presented 
into the hospital with a 7-day history of influenza-like symptoms, fever, abdominal and back pain 
that failed treatment with antibiotics. He was febrile, tachycardic, profoundly hypotensive and in 
respiratory distress. Aggressive resuscitation was initiated, but he progressed to decompensated 
shock, with cardiovascular collapse and respiratory failure, requiring intubation and inotropic 
support. He was started with broad spectrum antimicrobial medications. His family history was of 
a sibling who had cocciodioidomycosis manifested by fever, cough and isolated lung nodule and 
a positive serology test. Given his state, he was transferred to the authors institution for initiation 
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of extracorporeal membrane oxygenation. His laboratory exams were altered and indicated 
pancytopenia and acute renal failure. Chest X-ray demonstrated diffuse patchy opacities 
throughout both lung fields and bilateral pleural effusions. Echocardiogram showed underfilled, 
hyperdynamic left ventricle with well-preserved function and no structural abnormalities. 
Abdominal CT scan was remarkable for splenomegaly, and the brain CT scan was negative for 
acute intracranial pathology. A bone marrow aspirate performed on hospital day 2 demonstrated 
haemophagocytosis. The infectious workup was unremarkable, and unable to identify an infectious 
aetiology. Blood, urine, respiratory and bone marrow culture samples were all sterile, and the anti-
streptolysin O and anti-DNAse B were negative. HIV, EBV, herpes simplex and other viruses 
serology were negative. Serum coccidioidomycosis was also negative. Due to his progressive 
multi-organ failure, haematophagocytic lymphohistiocytosis was established and he received 
treatment for bacterial causes of this syndrome, but he died on the third day after admission. 
Autopsy findings were significant for active pulmonary coccidioidiomycosis, extensive pulmonary 
haematophagocytosis and marked bone marrow histiocytosis. Final diagnosed was of 
haemophagocytic lymphohistiocytosis due to coccidioidomycosis infection [24]. 
Parikh and col in 2015, reported a 70 year-old male was admitted into a hospital with abdomen 
pain and inability to pass stool for 8 days. He didn’t show any signs of fever, nausea, vomiting and 
change in urine or faeces colour and didn’t have history of tuberculosis, diabetes mellitus, 
hypertension or bronchial asthma. Despite a tender and distended abdomen, his vitals and blood 
tests were normal. Microscopy of the small intestine during autopsy showed features of gangrene 
with perforation, superadded infection and the presence of slender septate, acutely branched fungal 
filaments of Aspergillus spp., which were further confirmed with special stain of Gomori 
Methanamine Silver (GMS) [25]. 
In 2015, Yuan and Prayson reported a case of a 55 year old woman that presented new onset 
headaches behind the left eye one year prior to death. She developed blurred vision and scotoma 
3 months later. After a left temporal artery biopsy was negative for giant cell arteritis, she received 
a trial treatment of indomethacin. Magnetic resonance imaging (MRI) showed enhancement and 
thickening of the left optic nerve. Because of the loss of vision and a positive antinuclear antibody 
test, she was given high dose of steroids. Although it improved her headache, it didn’t improve her 
sight. Screening for infectious diseases including fungal infections such as Aspergillus failed to 
demonstrate an infectious aetiology. Shortly before death, she developed right-sided weakness and 
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evidence of a pontine infarct on MRI studies. After autopsy, histologic sections taken from the left 
optic nerve showed an abscess and evidence of fungal hyphae morphologically consistent with 
Aspergillus spp.[26]. 
A fatal case of disseminated histoplasmosis was reported by Bonsignore and col in 2017 of a 43 
year-old floriculturist Italian woman. She was in good health and good medical history and 
serology. All blood tests were normal. Albeit being splenectomized before, she was considered 
immunocompetent. The patient died 3 days after admission, 35 days after symptoms onset. 
Histopathological studies were conducted and indicated disseminated histoplasmosis with 
multivisceral involvement. Post-mortem blood culture findings confirmed positivity for the 
pathogen. A multivisceral infiltrate of histiocyte-macrophage cells was evident. The cytoplasm of 
these phagocytes was laden with black granules, whose morphology was consistent with 
Histoplasma. Lung specimens showed microfoci of confluent, cheese-like necrosis with sero-
fibrinous exudate and a weak surrounding inflammatory response; Grocott staining identified 
fungal hyphae and spores indicative of complicating Candida albicans infection [27]. 
 
DISCUSSION 
Amongst the cases presented, Aspergillus was the main cause of death. These findings match what 
Saini and col described in 2010. In their study, they reviewed neuroimaging features of 
craniocebral aspergillosis infection in immunocompetent patients. They searched the database of 
medical records on their institute for fungal infections of the brain and craniofacial area. Of the 22 
patients found to have fungal infection in a 12-year period, 12 were of immunocompetent hosts 
with aspergillosis [28]. 
The 1-3 β D glucan was tested only in two cases [20,21], indicating that fungal infections weren’t 
primarily suspected due to the immunocompetent state of the hosts and that it is an important tool 
to diagnose these mycoses. Obayashi and col published in 2008 a study where they evaluated the 
effectiveness of the 1-3 β D glucan test for diagnosis of invasive fungal infections. They studied 
autopsy cases from 6 years  that had 1-3 β D glucan tested within 2 weeks before death and 
concluded that this test is an effective diagnostic tool for invasive fungal infections [29]. 
Antimicrobial treatment was initiated before microbiological assessment was performed, 
misleading the course of treatment to antibacterial instead of antifungal agents. In these cases, 
Gram stain is recommended to verify which type of microorganism is causing the infection. If 
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identified as bacterium, its corresponding treatment can be followed. Yoshimura and col (2017) 
researched the impact of Gram stain results on initial treatment selection in patients with ventilator-
associated pneumonia and concluded that antimicrobial treatment based on Gram stain results 
restrict the administration of broad-spectrum antibiotics without risk of treatment failure [30]. 
Autopsy gave the definite diagnosis in 10 of the cases presented. It’s important to notice the value 
of these findings, for not only these subjects wouldn’t have the right cause of death determined, 
but also because it’s a matter of public health. In 2012, Colombo and col assessed the importance 
of necropsy studies to provide data on aetiology, underlying diseases  and risk factors associated 
with fungal diseases, that are essential to improve treatment protocols [31]. Knoke, Bernhardt and 
Schwesinger (2008) concluded in their review that autopsy remains an important tool for quality 
control in medical diagnostic and therapeutic activity and that only an exact death statistic makes 
specific health care possible [32]. 
 
CONCLUSIONS 
Invasive fungal infections in immunocompetent hosts are rare, especially those with fatal 
disclosures. In most cases, mycoses in these subjects are treatable and cured as they have full 
immune responses. Most cases of invasive fungal infections, especially fatal ones, occur in 
immunocompromised hosts. Although uncommon, mycoses can have deadly outcomes in 
immunocompetents as well. 
Since invasive fungal infections are most commonly found in immunocompromised patients, these 
diseases are difficult to diagnose in immunocompetent, for they are not expected in this group and 
main diagnosis is often based on clinical signs, leading to error in diagnostic. Definite diagnoses 
occur mostly after autopsy. Proper and early mycoses diagnosis is necessary so survival rates are 
higher within this population.  
Data like profession, age and local of residency are important to trace a profile of the patients that 
have each fungus, so that, in the moment of hospital admission, the physician can have solid 
indications of which mycosis the patients present and he will be able to give the proper treatment 
for the individual. 
Gram stain and  1-3 β D glucan tests are essential before starting antimicrobial therapy, for they 
can direct the course of treatment whether to antibiotic or antifungal agents and they can be carried 
out in almost any hospital or emergency centre worldwide, for they are cheap, simple and easy to  
13 
 
perform. When in life diagnosis is not possible, it is fundamental to have autopsies performed to 
aid in the profiling of infections aetiologies. 
In this review study, Aspergillus spp. was the most present fungus in mycoses cases in 
immunocompetent individuals, highlighting the need of attention in the search for the correct 
diagnosis since this fungus is very present in the environment. 
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